CSIMarket
 


Cumberland Pharmaceuticals Inc   (CPIX)
Other Ticker:  
 

Cumberland Pharmaceuticals Inc 's Long Term Debt to Equity

CPIX's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth




CPIX Long Term Debt to Equity (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Equity Change -9.69 % -8.07 % -10.76 % -10.02 % -9.34 %
Y / Y Long Term Debt Change -7.5 % -7.5 % 66.67 % 66.67 % 66.67 %
Long Term Debt to Equity MRQ 0.37 0.36 0.39 0.37 0.36
Overall Ranking # 870 # 1179 # 1293 # 1310 # 1313
Seq. Equity Change -2.43 % -1.2 % -3.69 % -2.72 % -0.68 %
Seq. Long Term Debt Change 0 % -7.5 % 0 % 0 % 0 %



Long Term Debt to Equity first quarter 2020 Comment
Despite long-term debt repayement of 0%, in I. Quarter ,Long Term Debt to Equity detoriated to 0.37, above company's average Long Term Debt to Equity.

Within Major Pharmaceutical Preparations industry in the first quarter 2020, 37 other companies have achieved lower Long Term Debt to Equity than Cumberland Pharmaceuticals Inc . While Long Term Debt to Equity total ranking has improved so far to 870, from total ranking in previous quarter at 1179.

Explain Long Term Debt to Equity Ratio?
Learn more about CPIX
Long Term Debt to Equity Ratio CPIX on the trailing twelve month basis
Long Term Debt to Equity first quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 38
Healthcare Sector # 120
Overall Market # 870


Long Term Debt to Equity Statistics
High Average Low
0.39 0.15 0.02
(Sep 30 2019)   (Jun 30 2015)




Financial Statements
Cumberland Pharmaceuticals Inc 's Equity $ 50 Millions Visit CPIX's Balance sheet
Cumberland Pharmaceuticals Inc 's Long Term Debt $ 19 Millions Visit CPIX's Balance sheet
Source of CPIX's Sales Visit CPIX's Sales by Geography




Companies with similar Long Term Debt to Equity in the quarter endingMar 31 2020, within Major Pharmaceutical Preparations Industry Long Term Debt to EquityMar 31 2020 MRQ Long Term DebtMar 31 2020 MRQ Equity
Mylan N v   0.99 $ 11,197.800  Millions$ 11,262.700  Millions
Progenics Pharmaceuticals Inc  0.99 $ 30.166  Millions$ 30.613  Millions
Chembio Diagnostics Inc   0.98 $ 17.771  Millions$ 18.133  Millions
Fortress Biotech Inc   0.94 $ 70.866  Millions$ 75.285  Millions
Ani Pharmaceuticals Inc  0.93 $ 188.094  Millions$ 201.171  Millions
Innoviva inc   0.93 $ 379.152  Millions$ 405.869  Millions
Retrophin Inc   0.92 $ 207.412  Millions$ 225.748  Millions
Arcturus Therapeutics Holdings Inc   0.88 $ 15.028  Millions$ 16.982  Millions
Bristol Myers Squibb Co  0.86 $ 42,844.000  Millions$ 49,977.000  Millions
Pacira Biosciences inc   0.83 $ 310.078  Millions$ 374.037  Millions
Merck and Co Inc   0.82 $ 21,637.000  Millions$ 26,300.000  Millions
Harrow Health Inc   0.77 $ 11.605  Millions$ 15.028  Millions
Biodelivery Sciences International Inc   0.77 $ 58.634  Millions$ 76.588  Millions
Lipocine Inc   0.72 $ 4.688  Millions$ 6.553  Millions
Reata Pharmaceuticals Inc   0.68 $ 155.506  Millions$ 228.647  Millions
Ligand Pharmaceuticals Incorporated  0.67 $ 444.432  Millions$ 661.896  Millions
Titan Pharmaceuticals Inc  0.66 $ 3.500  Millions$ 5.276  Millions
Horizon Therapeutics Public Limited Company  0.62 $ 1,358.360  Millions$ 2,188.339  Millions
Xoma Corp  0.61 $ 25.141  Millions$ 41.119  Millions
Verrica Pharmaceuticals Inc   0.61 $ 34.434  Millions$ 56.608  Millions
Sarepta Therapeutics Inc   0.60 $ 687.953  Millions$ 1,144.828  Millions
Supernus Pharmaceuticals inc   0.57 $ 349.232  Millions$ 613.383  Millions
Apellis Pharmaceuticals inc   0.56 $ 144.561  Millions$ 258.997  Millions
Ptc Therapeutics inc   0.56 $ 294.574  Millions$ 528.734  Millions
Revance Therapeutics Inc   0.56 $ 171.305  Millions$ 308.375  Millions
Pfizer Inc  0.56 $ 36,281.000  Millions$ 65,338.000  Millions
Abbott Laboratories  0.55 $ 16,804.000  Millions$ 30,427.000  Millions
Aimmune Therapeutics Inc   0.55 $ 128.250  Millions$ 235.047  Millions
Aveo Pharmaceuticals Inc   0.52 $ 3.610  Millions$ 7.008  Millions
Kala Pharmaceuticals Inc   0.50 $ 71.438  Millions$ 141.510  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GEVO's Profile

Stock Price

GEVO's Financials

Business Description

Fundamentals

Charts & Quotes

GEVO's News

Suppliers

GEVO's Competitors

Customers & Markets

Economic Indicators

GEVO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071